Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs
2018; AMCP; Volume: 25; Issue: 1 Linguagem: Inglês
10.18553/jmcp.2018.18058
ISSN2376-1032
AutoresJanet H. Ford, Krista Schroeder, Allen W. Nyhuis, Shonda A. Foster, Sheena K. Aurora,
Tópico(s)Psychosomatic Disorders and Their Treatments
ResumoMigraine is a common and disabling neurological disease associated with substantial economic burden. Among patients with migraine, it is unknown if cost differences exist when preventive migraine medication (PMM) switches occur.
Referência(s)